Covid-19 Vaccines and Variant News: Live Updates
A healthcare worker prepares a Pfizer-BioNTech coronavirus booster shot in Los Angeles earlier this year.Caroline Brehman/EPA, via ShutterstockAn independent panel...
Coronavirus
Top NY Doctor: New COVID Wave Is Starting, With the ‘Worst Version’ of Omicron
A new COVID wave appears to be starting in New York City, fueled by the strongest subvariant of the omicron...
Antibodies From Llama Blood Can Protect Against COVID, Future and Other Coronaviruses
Aside from the vaccine, one of the biggest reasons we’ve seen a drop in COVID deaths since the start of...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2TNGQZGFOSVHXFL73374DLCA.jpg "U.S. FDA will decide on redesigned COVID vaccines by early July")
U.S. FDA will decide on redesigned COVID vaccines by early July
June 28 (Reuters) - U.S. regulators plan to decide by early July on whether to change the design of COVID-19...
Coronavirus easier to get, harder to avoid in California
The number of coronavirus cases reported in California is on the brink of crossing 10 million, a milestone that probably...
WHO official: Individuals can get ‘unlucky’ with long COVID
David Nabarro at the UN in 2019. Photo by Lev Radin/Pacific Press/LightRocket via Getty Images A World Health Organization official...
China’s first mRNA vaccine is close — will that solve its COVID woes?
Clinical trials for an mRNA vaccine called ARCoV are under way in China.Credit: Ju Huanzong/Xinhua/Alamy China is getting closer to...
Matteo Berrettini, 2021 runner-up, withdraws from Wimbledon after positive COVID-19 test
6:37 AM ETAssociated Press WIMBLEDON, England -- Matteo Berrettini, last year's runner-up at Wimbledon, dropped out of the grass-court Grand...
2021 Wimbledon runner-up Matteo Berrettini out with COVID-19
WIMBLEDON – Matteo Berrettini, last year's runner-up at Wimbledon, dropped out of the grass-court Grand Slam tournament hours before he...
F.D.A. Panel to Consider If Next Generation Vaccines Should Target Omicron
An independent panel of advisers to the Food and Drug Administration will meet on Tuesday to consider options for updating...